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To the Editor: Extended-spectrum beta-
lactamase-producing Enterobacteriaceae 
(ESBL-PE) produce enzymes that confer 
resistance to penicillins, cephalosporins 
and monobactams.[1] ESBL-PE represent a 
global concern in humans, in animals and 
in the environment and have therefore been 
recognised as pathogens of critical priority. [2] 
Of additional concern is the emergence 
of the plasmid-borne colistin resistance 
(mcr-1) genes that encode for resistance to 
polymyxins, the antibiotics of last resort 
for treatment of serious difficult-to-treat 
infections.[3] They have both been detected 
in developed and developing countries, and 
food animals have been recognised as their 
principal reservoir.[4]
Nasal and rectal swabs were collected 
from 432 pigs during a multicentre study 
carried out from March to October 2016 in 
five abattoirs in Cameroon (n=3) and South 
Africa (SA) (n=2). Samples were screened 
on a selective medium and puta tive  ESBL-
PE were tested for their antimicrobial 
susceptibility using the Vitek 2 System and 
Vitek 2 Gram Negative Susceptibility card 
(AST-N255) (bioMérieux, France). The 
results were interpreted according to the 
Clinical and Laboratory Standards Institute 
(CLSI) guideline,[5] with the exception of 
colistin, amoxicillin plus clavulanic acid, 
piperacillin plus tazobactam and ami kacin, 
which were based on European Committee 
on Antimicrobial Susceptibility Testing 
(EUCAST) breakpoints.[6] Closely related 
isolates underwent whole-genome sequen-
cing (WGS) analysis on an Illumina MiSeq 
platform (Illumina Inc., USA) with 100  × 
coverage. ResFinder,[7] VirulenceFinder [8] 
and PlasmidFinder[9] were used to identify 
resistance genes, virulence factors and 
plasmids, respectively. The multi-locus 
sequence type was also determined from 
WGS data.
One of the ESBL-producing Escherichia coli 
isolated, PN256E8 (GenBank accession no. 
QJRZ00000000), showed resistance to several 
beta-lactam and non-beta-lactam antibiotics, 
including colistin. This resistance phenotype 
was corroborated by the identification of 
the blaTEM-1B and blaCTX-M-55 genes through 
WGS, which also evidenced the colistin 
(mcr-1)-resistant gene (Table 1). The isolate 
PN256E8 was ascribed to the sequence 
type (ST) 446 and phylogenetic group A. 
It further harboured two virulence factors 
and two replicons along with three plasmid 
incompatibility groups, IncHI2 (ST-3-like), 
IncHI2A (ST-3-like) and IncN (ST-1).
To the best of our knowledge, this is the 
first report on the presence of an mcr-1 
encoding colistin resistance in ESBL-E. coli 
ST446 isolated from a pig abattoir in SA. The 
dissemination of mcr-1-producing E. coli 
strains in food animals and humans has been 
reported worldwide. In SA, a 79% preva-
lence of mcr-1 in colistin-resistant cultures 
of E.  coli was reported in a nationwide 
surveillance programme of poultry settings. 
The mcr-1 gene was detected among clinical 
E. coli isolates of hospitalised patients 
(n=3) and outpatients (n=6) not previously 
exposed to colistin.[10] Furthermore, in the 
Western Cape region, 83% of clinical colistin-
resistant Enterobacteriaceae harboured the 
mcr-1 gene.[3] The concomitant presence 
of ESBL and mcr-1 genes in E. coli ST 
446 is an important food safety and public 
health concern, as these resistances could be 
transferred from commensal to pathogenic 
bacteria prevailing in the food chain and 
subsequently disseminate to communities 
and/or healthcare settings. Increased 
surveil lance of ESBL producers for colistin 
resistance is essential to monitor their 
acquisition and spread. Efforts to ensure 
rational antibiotic use in agriculture are vital 
to preserve antibiotics for future generations.
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